The board of directors of Bamboos Health Care Holdings Limited announced that, due to her other business arrangements and commitments, with effect from 17 August 2021, Ms. Chhoa Peck Lim Bella (i) has resigned as an independent non- executive Director of the Company; and (ii) has ceased to be the chairman of the Compliance Committee, a member of the Audit Committee and a member of the Nomination Committee of the Company. Ms. Chhoa has confirmed that she has no disagreement with the Board and there is no matter in relation to her resignation that needs to be brought to the attention of the shareholders of the Company or The Stock Exchange of Hong Kong Limited. The Board further announces that, with effect from 17 August 2021 upon expiry of his current term of appointment with the Company, Dr. Ko Wing Man (i) has resigned as an independent non-executive Director of the Company; and (ii) has ceased to be the chairman of the Remuneration Committee and a member of the Nomination Committee of the Company, in order to devote more time to his other business commitments. The Board announced that, with effect from 17 August 2021, Mr. Lam Kwok Ming has been appointed as an independent non-executive Director of the Company, a member of the Audit Committee, a member of the Nomination Committee as well as the chairman of the Remuneration Committee of the Company. After due and careful considerations of the Company's current circumstances and state of affairs, the Board announces that with effect from 17 August 2021, following the resignation of Ms. Chhoa, each of Dr. Chan Kai Yue Jason and Mr. Wong Kon Man Jason has ceased to be a member of the Compliance Committee and subsequently the Compliance Committee has ceased to function. Following the above-mentioned reorganisation and with effect from 17 August 2021, in order to further enhance the corporate governance structure and improve the efficiency in decision making of the Board, the Audit Committee has taken up the roles and responsibilities of the Compliance Committee and shall continue to review and monitor the corporate governance functions and duties so as to ensure a high standard of corporate governance practices in the Group and assure that the Group is in compliance with prevailing statutory requirements, guidelines and regulations. Following the above-mentioned resignation, Ms. Chhoa has ceased to be the chairman of the Compliance Committee, a member of the Audit Committee and a member of the Nomination Committee with effect from 17 August 2021. Following the above-mentioned resignation, Dr. Ko has ceased to be the chairman of the Remuneration Committee and a member of the Nomination Committee with effect from 17 August 2021. In this regard, Dr. Chan Kai Yue Jason has been appointed as a member of the Nomination Committee with effect from 17 August 2021. Following the above-mentioned appointment, Mr. Lam has also been appointed as the chairman of the Remuneration Committee, a member of the Audit Committee and a member of the Nomination Committee with effect from 17 August 2021.